{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T09:31:34Z","timestamp":1753522294527},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2002,8,27]],"date-time":"2002-08-27T00:00:00Z","timestamp":1030406400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2002,9]]},"DOI":"10.1038\/sj.eye.6700163","type":"journal-article","created":{"date-parts":[[2002,9,3]],"date-time":"2002-09-03T19:11:13Z","timestamp":1031080273000},"page":"587-593","source":"Crossref","is-referenced-by-count":14,"title":["Corticosteroid-induced osteoporosis in patients with uveitis"],"prefix":"10.1038","volume":"16","author":[{"given":"N P","family":"Jones","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L C","family":"Anderton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F M","family":"Cheong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Whallett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M R","family":"Stanford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P I","family":"Murray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Lesnik-Oberstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Pavesio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2002,8,27]]},"reference":[{"key":"BF6700163_CR1","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1136\/bjo.81.4.260","volume":"81","author":"P Hodgkins","year":"1997","unstructured":"Hodgkins P, Hull RG, Evans AR, Jeffrey MN . Osteoporosis: a survey of consultant ophthalmologists. Br J Ophthalmol 1997; 81: 260","journal-title":"Br J Ophthalmol"},{"key":"BF6700163_CR2","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1136\/bmj.313.7053.344","volume":"313","author":"LJ Walsh","year":"1996","unstructured":"Walsh LJ, Wong CA, Pringle M, Tattersfield AE . Use of oral corticosteroids in the community and the prevention of secondary osteoporosis: a cross sectional study. Br Med J 1996; 313: 344\u2013346","journal-title":"Br Med J"},{"key":"BF6700163_CR3","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1136\/bjo.82.6.704","volume":"82","author":"R Stanbury","year":"1998","unstructured":"Stanbury R, Graham EM . Systemic corticosteroid therapy \u2013 side effects and their management. Br J Ophthalmol 1998; 82: 704\u2013708","journal-title":"Br J Ophthalmol"},{"key":"BF6700163_CR4","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/S0002-9394(00)00659-0","volume":"130","author":"DA Jabs","year":"2000","unstructured":"Jabs DA, Rosenbaum JT, Foster CS, Holland GN, Jaffe GJ, Louie JS et al. Perspective: guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. Am J Ophthalmol 2000; 130: 492\u2013513","journal-title":"Am J Ophthalmol"},{"key":"BF6700163_CR5","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1093\/rheumatology\/33.4.348","volume":"33","author":"H Mulder","year":"1994","unstructured":"Mulder H, Struys SA . Intermittent cyclical etidronate in the prevention of corticosteroid-induced bone loss. Br J Rheumatol 1994; 33: 439\u2013447","journal-title":"Br J Rheumatol"},{"key":"BF6700163_CR6","doi-asserted-by":"publisher","first-page":"353","DOI":"10.7326\/0003-4819-112-5-352","volume":"112","author":"BP Lukert","year":"1990","unstructured":"Lukert BP, Raisz LG . Glucocorticoid induced osteoporosis; pathogenesis and management. Ann Intern Med 1990; 112: 353\u20133564","journal-title":"Ann Intern Med"},{"key":"BF6700163_CR7","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/ageing\/21.2.139","volume":"21","author":"SP Baillie","year":"1992","unstructured":"Baillie SP, Davison CE, Johnson FJ, Francis RM . Pathogenesis of vertebral crush fractures in men. Age Ageing 1992; 21: 139\u2013141","journal-title":"Age Ageing"},{"key":"BF6700163_CR8","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/978-94-010-9580-8_5","volume-title":"Osteoporosis: Pathogenesis and Management","author":"DM Reid","year":"1990","unstructured":"Reid DM . Corticosteroid osteoporosis. In: Francis RM (ed). Osteoporosis: Pathogenesis and Management Kluwer: Lancaster 1990 103\u2013144"},{"key":"BF6700163_CR9","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1136\/ard.54.1.49","volume":"54","author":"C Cooper","year":"1995","unstructured":"Cooper C, Coupland C, Mitchell M . Rheumatoid arthritis, corticosteroid therapy and hip fracture. Ann Rheum Dis 1995; 54: 49\u201352","journal-title":"Ann Rheum Dis"},{"key":"BF6700163_CR10","first-page":"137","volume-title":"Osteoporosis","author":"B Lees","year":"1998","unstructured":"Lees B, Banks LM, Stevenson JC . Bone mass measurements In: Stevenson JC, Lindsay R (eds) Osteoporosis Chapman & Hall: London 1998 pp 137\u2013155"},{"key":"BF6700163_CR11","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1210\/jcem-39-2-274","volume":"39","author":"TJ Hahn","year":"1974","unstructured":"Hahn TJ, Boisseau VC, Avioli LV . Effect of chronic corticosteroid administration on diaphyseal and metaphyseal bone mass. J Clin Endocrinol Metab 1974; 39: 274\u2013282","journal-title":"J Clin Endocrinol Metab"},{"key":"BF6700163_CR12","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.2214\/ajr.126.6.1300","volume":"126","author":"MN Mueller","year":"1976","unstructured":"Mueller MN . Effects of corticosteroids on bone mineral in rheumatoid arthritis and asthma. Am J Roentgenol 1976; 126: 1300","journal-title":"Am J Roentgenol"},{"key":"BF6700163_CR13","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1136\/bmj.293.6560.1463","volume":"293","author":"DM Reid","year":"1986","unstructured":"Reid DM, Nicoll JJ, Smith MA et al. Corticosteroids and bone mass in asthma: comparisons with rheumatoid arthritis and polymyalgia rheumatica. Br Med J 1986; 293: 1463\u20131464","journal-title":"Br Med J"},{"key":"BF6700163_CR14","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1089\/thy.1997.7.579","volume":"7","author":"L Baschieri","year":"1997","unstructured":"Baschieri L, Antonelli A, Nardi S et al. Intravenous immunoglobulin versus corticosteroid in treatment of Graves\u2019 ophthalmopathy. Thyroid 1997; 7: 579\u2013585","journal-title":"Thyroid"},{"key":"BF6700163_CR15","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/S0161-6420(96)30618-0","volume":"103","author":"RR Tamesis","year":"1996","unstructured":"Tamesis RR, Rodriguez A, Christen WG, Akova YA, Messmer E, Foster CS . Systemic drug toxicity trends in immunosuppressive therapy of immune and inflammatory ocular disease. Ophthalmology 1996; 103: 768\u2013775","journal-title":"Ophthalmology"},{"key":"BF6700163_CR16","first-page":"804","volume":"18","author":"BA Michel","year":"1991","unstructured":"Michel BA, Bloch DA, Fries JF . Predictors of fractures in early rheumatoid arthritis. J Rheumatol 1991; 18: 804\u2013808","journal-title":"J Rheumatol"},{"key":"BF6700163_CR17","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1056\/NEJM198308043090502","volume":"309","author":"AD Adinoff","year":"1983","unstructured":"Adinoff AD, Hollister JR . Steroid-induced fractures and bone loss in patients with asthma. N Engl J Med 1983; 309: 265\u2013268","journal-title":"N Engl J Med"},{"key":"BF6700163_CR18","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1136\/bmj.2.5862.325","volume":"2","author":"JM Aitken","year":"1973","unstructured":"Aitken JM, Hart DM, Anderson JB et al. Osteoporosis after oophorectomy for malignant disease in premenopausal women. Br Med J 1973; 2: 325\u2013328","journal-title":"Br Med J"},{"key":"BF6700163_CR19","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1097\/00005792-197609000-00004","volume":"55","author":"AJ Greenstein","year":"1976","unstructured":"Greenstein AJ, Janowitz HD, Sachar DB . The extra-intestinal complications of Crohn\u2019s disease and ulcerative colitis: a study of 700 patients. Medicine 1976; 55: 401\u2013412","journal-title":"Medicine"},{"key":"BF6700163_CR20","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1210\/jcem-39-2-274","volume":"39","author":"TJ Hahn","year":"1974","unstructured":"Hahn TJ, Boisseau VC, Avioli LV . Effect of chronic corticosteroid administration on diaphyseal and metaphyseal bone mass. Clin Endocrinol Metab 1974; 39: 274\u2013282","journal-title":"Clin Endocrinol Metab"},{"key":"BF6700163_CR21","first-page":"257","volume":"94","author":"PL Selby","year":"1988","unstructured":"Selby PL . Osteopenia and diabetes. Diabetic Med 1988; 94: 257\u2013264","journal-title":"Diabetic Med"},{"key":"BF6700163_CR22","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1001\/jama.1991.03460090081037","volume":"265","author":"NA Rigotti","year":"1991","unstructured":"Rigotti NA, Neer RM, Skates SJ, Herzog DB, Nussbaum SR . The clinical course of osteoporosis in anorexia nervosa. A longitudinal study of cortical bone mass. JAMA 1991; 265: 1133\u20131138","journal-title":"JAMA"},{"key":"BF6700163_CR23","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1001\/jama.1965.03090020005001","volume":"193","author":"GC Griffith","year":"1965","unstructured":"Griffith GC, Nicholas G, Asher JD, Flanagan B . Heparin osteoporosis. JAMA 1965; 193: 91\u201394","journal-title":"JAMA"},{"key":"BF6700163_CR24","doi-asserted-by":"publisher","first-page":"492","DOI":"10.2106\/00004623-196547030-00005","volume":"47B","author":"PD Saville","year":"1965","unstructured":"Saville PD . Changes in bone mass with age and alcoholism. J Bone Joint Surg 1965; 47B: 492\u2013499","journal-title":"J Bone Joint Surg"},{"key":"BF6700163_CR25","first-page":"1","volume":"41(suppl)","author":"BEC Nordin","year":"1987","unstructured":"Nordin BEC, Polley KJ . Metabolic consequences of the menopause. Calcif Tissue Int 1987; 41(suppl): 1\u201359","journal-title":"Calcif Tissue Int"},{"key":"BF6700163_CR26","doi-asserted-by":"publisher","first-page":"961","DOI":"10.7326\/0003-4819-125-12-199612150-00004","volume":"125","author":"LM Buckley","year":"1996","unstructured":"Buckley LM, Leib ES, Cartularo KS, Vacek PM, Cooper SM . Calcium and vitamin D3 supplementation prevents bone loss in the spine secondary to low-dose corticosteroids in patients with rheumatoid arthritis. Ann Intern Med 1996; 125: 961\u2013968","journal-title":"Ann Intern Med"},{"key":"BF6700163_CR27","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S0002-9343(99)80154-5","volume":"99","author":"A Struys","year":"1995","unstructured":"Struys A, Snelder AA, Mulder H . Cyclical etidronate reverses bone loss of the spine and proximal femur in patients with established corticosteroid-induced osteoporosis. Am J Med 1995; 99: 235\u2013242","journal-title":"Am J Med"},{"key":"BF6700163_CR28","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1056\/NEJM199306173282404","volume":"328","author":"P Sambrook","year":"1993","unstructured":"Sambrook P, Birmingham J, Kelly P et al. Prevention of corticosteroid osteoporosis. A comparison of calcium, calcitriol, and calcitonin. N Engl J Med 1993; 328: 1747\u20131752","journal-title":"N Engl J Med"},{"key":"BF6700163_CR29","first-page":"CD001983","volume":"2","author":"A Cranney","year":"2000","unstructured":"Cranney A, Welch V, Adachi JD et al. Calcitonin for the treatment and prevention of corticosteroid-induced osteoporosis. Cochrane Database Syst Rev 2000; 2: CD001983","journal-title":"Cochrane Database Syst Rev"},{"key":"BF6700163_CR30","unstructured":"Anon. Guidance on the Prevention and Management of Corticosteroid Induced Osteoporosis National Osteoporosis Society: Bath 1998"},{"key":"BF6700163_CR31","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1046\/j.1365-2362.1996.00170.x","volume":"26","author":"D Thiebaud","year":"1996","unstructured":"Thiebaud D, Krieg MA, Gillard-Berguer D, Jacquet AF, Goy JJ, Burckhardt P . Cyclosporine induces high bone turnover and may contribute to bone loss after heart transplantation. Eur J Clin Invest 1996; 26: 549\u2013555","journal-title":"Eur J Clin Invest"},{"key":"BF6700163_CR32","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1359\/jbmr.1997.12.4.607","volume":"12","author":"AR Bowman","year":"1997","unstructured":"Bowman AR, Sass DA, Dissanayake IR et al. The role of testosterone in cyclosporine-induced osteopenia. J Bone Miner Res 1997; 12: 607\u2013615","journal-title":"J Bone Miner Res"},{"key":"BF6700163_CR33","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1002\/(SICI)1097-4644(19981001)71:1<116::AID-JCB12>3.0.CO;2-L","volume":"71","author":"J Stekelenburg","year":"1998","unstructured":"Stekelenburg J, Klein BY, Ben-Bassat H, Rojansky N . Opposing effects of cyclosporin A and tryphostin AG-1478 indicate a role for Src protein in the cellular control of mineralisation. J Cell Biochem 1998; 71: 116\u2013126","journal-title":"J Cell Biochem"},{"key":"BF6700163_CR34","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1742-1241.1998.tb11599.x","volume":"52","author":"FH Anderson","year":"1998","unstructured":"Anderson FH . Osteoporosis in men. Int J Clin Pract 1998; 52: 176\u2013180","journal-title":"Int J Clin Pract"},{"key":"BF6700163_CR35","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1007\/s001980070037","volume":"11","author":"LJ Melton","year":"2000","unstructured":"Melton LJ, Khosla S, Achenbach SJ, O\u2019Connor MK, O\u2019Fallon WM, Riggs BL . Effects of body size and skeletal site on the estimated prevalence of osteoporosis in women and men. Osteoporos Int 2000; 11: 977\u2013983","journal-title":"Osteoporos Int"},{"key":"BF6700163_CR36","doi-asserted-by":"publisher","first-page":"452","DOI":"10.7326\/0003-4819-123-6-199509150-00010","volume":"123","author":"N Kelepouris","year":"1995","unstructured":"Kelepouris N, Harper KD, Gannon F, Kaplan FS, Haddad JG . Severe osteoporosis in men. Ann Intern Med 1995; 123: 452\u2013460","journal-title":"Ann Intern Med"},{"key":"BF6700163_CR37","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s001980050225","volume":"10","author":"E Legrand","year":"1999","unstructured":"Legrand E, Chappard D, Pascaretti C, Duquenne M, Rondeau C, Simon Y et al. Bone mineral density and vertebral fractures in men. Osteoporos Int 1999; 10: 265\u2013270","journal-title":"Osteoporos Int"},{"key":"BF6700163_CR38","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1359\/jbmr.1998.13.12.1915","volume":"13","author":"LJ Melton","year":"1998","unstructured":"Melton LJ, Atkinson EJ, O\u2019Connor MK, O\u2019Fallon WM, Riggs BL . Bone density and fracture risk in men. J Bone Miner Res 1998; 13: 1915\u20131923","journal-title":"J Bone Miner Res"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6700163.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6700163","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6700163.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,6]],"date-time":"2024-01-06T19:58:23Z","timestamp":1704571103000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6700163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,8,27]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2002,9]]}},"alternative-id":["BF6700163"],"URL":"https:\/\/doi.org\/10.1038\/sj.eye.6700163","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,8,27]]}}}